CorMedix announced that the LDO (Large Dialysis) customer has commenced ordering and its implementation will target at least 50% more patients than previously communicated. With that CorMedix has raised their sales guidance from 31M to 35-40M.
When they fully onboard this LDO they can see their revenue grow as much by a factor of 10, the math is on my reply to ryshab post about CRMD. They are firing on all cylinders with their run rate P/E at 13.5 it has plenty of room to grow as these numbers are reported on its earning report. I am raising them to a mid position from a small. Only negative I see is they can only grow 25x in their TAM and I don’t know how long it will take to get approval for other types of catheters.
Drew